Soleus Capital Management, L.P. - Q2 2021 holdings

$650 Million is the total value of Soleus Capital Management, L.P.'s 65 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 65.3% .

 Value Shares↓ Weighting
BCAB SellBIOATLA INC$118,420,000
-26.7%
2,794,233
-12.1%
18.21%
-37.5%
EPIX BuyESSA PHARMA INC$63,943,000
+6.3%
2,238,104
+8.1%
9.83%
-9.2%
CCCC BuyC4 THERAPEUTICS INC$32,949,000
+91.9%
870,758
+87.6%
5.07%
+63.8%
NPCE NewNEUROPACE INC$32,935,0001,384,387
+100.0%
5.06%
THTX BuyTHERATECHNOLOGIES INC$27,269,000
+1.5%
7,028,096
+1.1%
4.19%
-13.4%
LNTH SellLANTHEUS HLDGS INC$25,255,000
+22.2%
913,697
-5.5%
3.88%
+4.3%
NVCR BuyNOVOCURE LTD$21,955,000
+556.0%
98,975
+290.8%
3.38%
+459.9%
EDAP BuyEDAP TMS S Asponsored adr$18,267,000
+771.5%
2,576,401
+932.4%
2.81%
+643.1%
ISEE SellIVERIC BIO INC$17,721,000
-15.2%
2,808,343
-16.9%
2.72%
-27.6%
CRSP NewCRISPR THERAPEUTICS AGnamen akt$16,693,000103,114
+100.0%
2.57%
NEO BuyNEOGENOMICS INC$15,900,000
+617.5%
352,007
+666.0%
2.44%
+512.8%
SKIN NewTHE BEAUTY HEALTH COMPANY$15,697,000934,316
+100.0%
2.41%
SRDX BuySURMODICS INC$15,103,000
+74.6%
278,404
+80.5%
2.32%
+49.0%
AZN SellASTRAZENECA PLCsponsored adr$14,984,000
+16.6%
250,146
-3.2%
2.30%
-0.5%
IRMD BuyIRADIMED CORP$14,622,000
+17.7%
497,179
+3.1%
2.25%
+0.5%
ITMR BuyITAMAR MED LTDsponsored ads$12,501,000
+93.3%
530,839
+96.5%
1.92%
+65.0%
CVRX NewCVRX INC$11,939,000426,394
+100.0%
1.84%
SIEN BuySIENTRA INC$11,634,000
+322.3%
1,461,563
+286.8%
1.79%
+260.7%
NTRA BuyNATERA INC$11,562,000
+45.5%
101,839
+30.2%
1.78%
+24.2%
HOWL NewWEREWOLF THERAPEUTICS INC$9,826,000563,396
+100.0%
1.51%
BuyGOSSAMER BIO INCnote 5.000% 6/0$8,596,000
+158.3%
10,700,000
+185.3%
1.32%
+120.3%
PCVX BuyVAXCYTE INC$8,456,000
+45.8%
375,650
+27.9%
1.30%
+24.4%
EOLS NewEVOLUS INC$7,337,000580,000
+100.0%
1.13%
INBX SellINHIBRX INC$6,682,000
-17.1%
242,789
-39.5%
1.03%
-29.2%
EDIT NewEDITAS MEDICINE INC$5,415,00095,600
+100.0%
0.83%
CUTR SellCUTERA INC$5,049,000
+40.0%
102,980
-14.2%
0.78%
+19.4%
YMAB NewY-MABS THERAPEUTICS INC$4,877,000144,300
+100.0%
0.75%
CMPS BuyCOMPASS PATHWAYS PLCsponsored ads$4,873,000
+209.6%
127,743
+198.9%
0.75%
+163.7%
KRYS SellKRYSTAL BIOTECH INC$4,592,000
-64.3%
67,529
-59.5%
0.71%
-69.5%
ASMB  ASSEMBLY BIOSCIENCES INC$4,353,000
-15.7%
1,122,0000.0%0.67%
-28.1%
XENE SellXENON PHARMACEUTICALS INC$4,351,000
-65.7%
233,697
-67.0%
0.67%
-70.7%
INSP NewINSPIRE MED SYS INC$4,165,00021,550
+100.0%
0.64%
MDXG SellMIMEDX GROUP INC$4,030,000
-21.7%
322,160
-35.6%
0.62%
-33.2%
RVMD BuyREVOLUTION MEDICINES INC$3,990,000
+52.1%
125,700
+119.8%
0.61%
+29.8%
CELC NewCELCUITY INC$3,956,000164,824
+100.0%
0.61%
LUNG NewPULMONX CORP$3,761,00085,250
+100.0%
0.58%
DYN BuyDYNE THERAPEUTICS INC$3,753,000
+38.6%
178,360
+2.3%
0.58%
+18.2%
AXGN NewAXOGEN INC$3,417,000158,140
+100.0%
0.52%
ARYD  ARYA SCIENCES ACQU CORP IVcl a$3,216,000
+2.4%
300,0000.0%0.50%
-12.5%
 BRIDGEBIO PHARMA INCnote 2.500% 3/1$3,201,000
-0.5%
1,950,0000.0%0.49%
-15.0%
BEAM NewBEAM THERAPEUTICS INC$2,844,00022,100
+100.0%
0.44%
GLTO SellGALECTO INC$2,723,000
-70.4%
538,152
-64.4%
0.42%
-74.7%
TKNO NewALPHA TEKNOVA INC$2,718,000114,546
+100.0%
0.42%
CDNA NewCAREDX INC$2,682,00029,300
+100.0%
0.41%
DXCM SellDEXCOM INC$2,512,000
+0.8%
5,884
-15.2%
0.39%
-14.0%
PODD NewINSULET CORP$2,465,0008,980
+100.0%
0.38%
FDMT Buy4D MOLECULAR THERAPEUTICS IN$2,427,000
-35.0%
100,800
+17.1%
0.37%
-44.6%
ESTA SellESTABLISHMENT LABS HLDGS INC$2,320,000
-39.3%
26,568
-56.6%
0.36%
-48.2%
MSON SellMISONIX INC$2,235,000
-62.1%
100,788
-66.6%
0.34%
-67.7%
GH NewGUARDANT HEALTH INC$2,173,00017,500
+100.0%
0.33%
HALO NewHALOZYME THERAPEUTICS INC$2,003,00044,100
+100.0%
0.31%
RFL SellRAFAEL HLDGS INC$1,876,000
-45.1%
36,742
-57.1%
0.29%
-53.2%
EIGR  EIGER BIOPHARMACEUTICALS INC$1,819,000
-3.8%
213,5190.0%0.28%
-17.9%
GLUE NewMONTE ROSA THERAPEUTICS INC$1,703,00075,000
+100.0%
0.26%
 CATABASIS PHARMACEUTICALS IN$1,635,000
-27.0%
775,0000.0%0.25%
-37.9%
CMAX NewCAREMAX INC$1,534,000118,900
+100.0%
0.24%
LYRA SellLYRA THERAPEUTICS INC$1,470,000
-73.3%
183,076
-61.5%
0.23%
-77.3%
RNLX SellRENALYTIX PLCads$1,460,000
-28.9%
47,300
-40.9%
0.22%
-39.2%
SBTX SellSILVERBACK THERAPEUTICS INC$967,000
-77.2%
31,306
-67.8%
0.15%
-80.5%
MGTA SellMAGENTA THERAPEUTICS INC$880,000
-25.7%
90,000
-10.0%
0.14%
-36.6%
TCRR SellTCR2 THERAPEUTICS INC$780,000
-75.1%
47,537
-66.6%
0.12%
-78.8%
EWTX SellEDGEWISE THERAPEUTICS INC$668,000
-79.4%
31,300
-68.7%
0.10%
-82.4%
NARI SellINARI MED INC$574,000
-75.0%
6,150
-71.3%
0.09%
-78.7%
KDMN SellKADMON HLDGS INC$335,000
-74.4%
86,442
-74.3%
0.05%
-78.0%
RPTX SellREPARE THERAPEUTICS INC$228,000
-94.4%
7,300
-94.5%
0.04%
-95.3%
CRDF ExitCARDIFF ONCOLOGY INC$0-42,684
-100.0%
-0.07%
HIMSWS ExitHIMS & HERS HEALTH INC*w exp 01/20/202$0-91,793
-100.0%
-0.07%
TPTX ExitTURNING POINT THERAPEUTICS I$0-5,577
-100.0%
-0.10%
MRTX ExitMIRATI THERAPEUTICS INC$0-3,466
-100.0%
-0.11%
RVNC ExitREVANCE THERAPEUTICS INC$0-31,136
-100.0%
-0.16%
ONCR ExitONCORUS INC$0-66,722
-100.0%
-0.17%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-99,992
-100.0%
-0.18%
KYMR ExitKYMERA THERAPEUTICS INC$0-28,116
-100.0%
-0.20%
ExitTRILLIUM THERAPEUTICS INC$0-103,819
-100.0%
-0.20%
VRDN ExitVIRIDIAN THERAPEUTICS INC$0-67,685
-100.0%
-0.20%
PIRS ExitPIERIS PHARMACEUTICALS INC$0-500,000
-100.0%
-0.23%
SRRK ExitSCHOLAR ROCK HLDG CORP$0-26,101
-100.0%
-0.24%
MORF ExitMORPHIC HLDG INC$0-21,500
-100.0%
-0.24%
DFHT ExitDEERFIELD HEALTHCARE TECH AC$0-118,900
-100.0%
-0.26%
OSH ExitOAK STR HEALTH INC$0-27,612
-100.0%
-0.27%
OCX ExitONCOCYTE CORP$0-297,000
-100.0%
-0.28%
STAA ExitSTAAR SURGICAL CO$0-16,700
-100.0%
-0.32%
MRK ExitMERCK & CO. INC$0-30,106
-100.0%
-0.42%
RNA ExitAVIDITY BIOSCIENCES INC$0-109,130
-100.0%
-0.43%
ALPN ExitALPINE IMMUNE SCIENCES INC$0-313,064
-100.0%
-0.60%
KNTE ExitKINNATE BIOPHARMA INC$0-109,000
-100.0%
-0.61%
ExitDARIOHEALTH CORP$0-178,814
-100.0%
-0.62%
PHG ExitKONINKLIJKE PHILIPS N Vny reg sh new$0-61,050
-100.0%
-0.63%
ALXN ExitALEXION PHARMACEUTICALS INC$0-25,318
-100.0%
-0.70%
EXEL ExitEXELIXIS INC$0-182,347
-100.0%
-0.74%
FLXN ExitFLEXION THERAPEUTICS INC$0-522,500
-100.0%
-0.84%
VSPR ExitVESPER HEALTHCARE ACQSTN COR$0-920,716
-100.0%
-1.79%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ESSA PHARMA INC16Q3 202310.8%
IRADIMED CORP16Q3 20235.8%
XENON PHARMACEUTICALS INC15Q3 20232.9%
IVERIC BIO INC14Q1 20236.5%
SURMODICS INC14Q3 20234.7%
NATERA INC13Q3 20233.9%
DEXCOM INC13Q2 20234.2%
NOVOCURE LTD13Q3 20233.4%
CRISPR THERAPEUTICS AG13Q2 20232.6%
LYRA THERAPEUTICS INC13Q3 20231.0%

View Soleus Capital Management, L.P.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Soleus Capital Management, L.P.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (650274000.0 != 650276000.0)

Export Soleus Capital Management, L.P.'s holdings